These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28656528)

  • 1. Chitinase 3-Like-1-Deficient Splenocytes Deteriorated the Pathogenesis of Acute Graft-Versus-Host Disease via Regulating Differentiation of Tfh Cells.
    Li Z; Lu H; Gu J; Liu J; Zhu Q; Lu Y; Wang X
    Inflammation; 2017 Oct; 40(5):1576-1588. PubMed ID: 28656528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitinase 3-like-1 deficient donor splenocytes accentuated the pathogenesis of acute graft-versus-host diseases through regulating T cell expansion and type I inflammation.
    Li Z; Gu J; Liu J; Zhu Q; Lu H; Lu Y; Rao J; Lu L; Wang X
    Int Immunopharmacol; 2017 May; 46():201-209. PubMed ID: 28324830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obese donor mice splenocytes aggravated the pathogenesis of acute graft-versus-host disease via regulating differentiation of Tregs and CD4
    Li Z; Gu J; Zhu Q; Liu J; Lu H; Lu Y; Wang X
    Oncotarget; 2017 Sep; 8(43):74880-74896. PubMed ID: 29088831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant germinal center formation, follicular T-helper cells, and germinal center B-cells were involved in chronic graft-versus-host disease.
    Shao L; Lie AK; Zhang Y; Wong CH; Kwong YL
    Ann Hematol; 2015 Sep; 94(9):1493-504. PubMed ID: 25963280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of interleukin-18 in acute graft-versus-host disease in mice.
    Itoi H; Fujimori Y; Tsutsui H; Matsui K; Sugihara A; Terada N; Hada T; Kakishita E; Okamura H; Hara H; Nakanishi K
    Transplantation; 2004 Nov; 78(9):1245-50. PubMed ID: 15548959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking activator protein 1 activity in donor cells reduces severity of acute graft-versus-host disease through reciprocal regulation of IL-17-producing T cells/regulatory T cells.
    Park MJ; Moon SJ; Lee SH; Kim EK; Yang EJ; Min JK; Park SH; Kim HY; Yang CW; Cho ML
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1112-20. PubMed ID: 24813170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect.
    Couturier M; Lamarthée B; Arbez J; Renauld JC; Bossard C; Malard F; Bonnefoy F; Mohty M; Perruche S; Tiberghien P; Saas P; Gaugler B
    Leukemia; 2013 Jul; 27(7):1527-37. PubMed ID: 23399894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Chitinase 3-Like-1 in Interleukin-18-Induced Pulmonary Type 1, Type 2, and Type 17 Inflammation; Alveolar Destruction; and Airway Fibrosis in the Murine Lung.
    Kang MJ; Yoon CM; Nam M; Kim DH; Choi JM; Lee CG; Elias JA
    Am J Respir Cell Mol Biol; 2015 Dec; 53(6):863-71. PubMed ID: 25955511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-bet is critical for the development of acute graft-versus-host disease through controlling T cell differentiation and function.
    Fu J; Wang D; Yu Y; Heinrichs J; Wu Y; Schutt S; Kaosaard K; Liu C; Haarberg K; Bastian D; McDonald DG; Anasetti C; Yu XZ
    J Immunol; 2015 Jan; 194(1):388-97. PubMed ID: 25404360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitinase-3-like 1 regulates T
    Curtiss ML; Rosenberg AF; Scharer CD; Mousseau B; Benavides NAB; Bradley JE; León B; Steele C; Randall TD; Lund FE
    Front Immunol; 2023; 14():1158493. PubMed ID: 37575256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIAS3 suppresses acute graft-versus-host disease by modulating effector T and B cell subsets through inhibition of STAT3 activation.
    Lee SH; Moon SJ; Park MJ; Kim EK; Moon YM; Cho ML
    Immunol Lett; 2014 Jul; 160(1):79-88. PubMed ID: 24718277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitinase-3-like-1 deficiency attenuates ethanol-induced liver injury by inhibition of sterol regulatory element binding protein 1-dependent triglyceride synthesis.
    Lee DH; Han JH; Lee YS; Jung YS; Roh YS; Yun JS; Han SB; Hong JT
    Metabolism; 2019 Jun; 95():46-56. PubMed ID: 30935969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tryptophan metabolite analog, N-(3,4-dimethoxycinnamonyl) anthranilic acid, ameliorates acute graft-versus-host disease through regulating T cell proliferation and polarization.
    Xu J; Wei J; Huang M; Zhu X; Guan J; Yin J; Xiao Y; Zhang Y
    Int Immunopharmacol; 2013 Nov; 17(3):601-7. PubMed ID: 23993943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-12 p40 messenger RNA expression in target organs during acute graft-versus-host disease. Possible involvement of IFN-gamma.
    Kichian K; Nestel FP; Kim D; Ponka P; Lapp WS
    J Immunol; 1996 Oct; 157(7):2851-6. PubMed ID: 8816389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential upregulation of interleukin-18 receptor alpha chain between CD4+ and CD8+ T cells during acute graft-versus-host disease in mice.
    Itoi H; Fujimori Y; Tsutsui H; Matsui K; Hada T; Kakishita E; Okamura H; Hara H; Nakanishi K
    J Interferon Cytokine Res; 2004 May; 24(5):291-6. PubMed ID: 15153312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
    Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
    Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHI3L1 alleviate acute liver injury by inhibiting Th1 cells differentiation through STAT3 signaling pathway.
    Zhang S; Dai X; Shi Y; Zhu X; Dai Y; Qian X; Gu J
    Ann Transl Med; 2021 Apr; 9(7):529. PubMed ID: 33987227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.
    Murphy WJ; Welniak LA; Taub DD; Wiltrout RH; Taylor PA; Vallera DA; Kopf M; Young H; Longo DL; Blazar BR
    J Clin Invest; 1998 Nov; 102(9):1742-8. PubMed ID: 9802888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
    Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
    Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protection and therapy effects of bortezomib in murine acute graft-versus-host disease.
    Li Z; Wu Q; Yan Z; Li D; Lu G; Mou W; Wu S; Pan X; Lu Q; Xu K
    Transplant Proc; 2013; 45(6):2527-35. PubMed ID: 23953575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.